Pfizer, BioNTech begin testing Omicron-specific vaccine for adults
Companies, agencies, institutions, etc
Pfizer
BioNTech
Omicron
COVID-19
Insider
Dolsten
Data
the Centers for Disease Control and Prevention
Delta
CDC
CNBC
People
Kathrin Jansen
Mikael Dolsten
Andrew Dunn
Albert Bourla
Groups
COVID-19
Physical locations
No matching tags
Places
No matching tags
Locations
US
Events
No matching tags
Summary
"While current research and real-world data show that boosters continue to provide a high level of protection against severe disease and hospitalization with Omicron, we recognize the need to be prepared in the event this protection wanes over time and to potentially help address Omicron and new variants in the future," Kathrin Jansen, Pfizer's senior vice president, said in a statement.Mikael Dolsten, Pfizer's chief scientific officer, told Insider's Andrew Dunn earlier this month that the shot would be ready by late March.But it was unclear whether the Omicron-specific shot would be needed, Dolsten said at the time.
As said here by Jake Epstein